Blockchain Registration Transaction Record

HIV Drugs from Online Marketplaces Declared Suspect by Advocacy Groups

ADAP Advocacy and PSM warn pharmacists that discounted HIV drugs from online P2P marketplaces are suspect products under FDA rules, urging quarantine and verification to protect patients.

This warning matters because it highlights a dangerous loophole in the pharmaceutical supply chain that could expose HIV/AIDS patients to counterfeit or substandard medications. Pharmacists who unknowingly purchase discounted HIV drugs from online P2P marketplaces risk dispensing illegitimate products, leading to treatment failure, drug resistance, or serious health consequences. Patients rely on the integrity of their medications, and this alert empowers pharmacists to take immediate action—quarantine and verify—to ensure safety. As fraud in the HIV drug supply chain has been documented over the past six years, this news serves as a critical reminder for all stakeholders to prioritize patient safety over cost savings.